Dave Singh
Impact in
- Pulmonary and Respiratory Medicine top 0.01%
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
- Respiratory and Cough-Related Research
- Inhalation and Respiratory Drug Delivery
- Neonatal Respiratory Health Research
- Physiology top 0.05%
- Asthma and respiratory diseases
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 340
- Respiratory Support and Mechanisms 89
- Respiratory and Cough-Related Research 70
- Inhalation and Respiratory Drug Delivery 49
- Neonatal Respiratory Health Research 19
- Physiology 245
- Asthma and respiratory diseases 240
- Co-authors
- Jørgen Vestbo (46 shared papers)ALBERTO PAPI (62 shared papers)David M.G. Halpin (39 shared papers)Fernando J. Martínez (47 shared papers)Andrew J. Higham (44 shared papers)Alvar Agusti Garcia-Navarro (19 shared papers)Umme Kolsum (29 shared papers)Simon Lea (38 shared papers)
- Journals
- Respiratory Research (51 papers)European Respiratory Journal (50 papers)International Journal of COPD (43 papers)American Journal of Respiratory and Critical Care Medicine (40 papers)CHEST Journal (24 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Dave Singh
573 papers receiving 29.3k citations
Dave Singh's Hit Papers
Peers
Comparison fields: 5 of 180
- Pulmonary and Respiratory Medicine 19.0k
- Physiology 9.6k
- Emergency Medical Services 1.6k
- Issues, ethics and legal aspects 221
- Immunology 1.9k
Countries citing papers authored by Dave Singh
This map shows the geographic impact of Dave Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dave Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dave Singh more than expected).
Fields of papers citing papers by Dave Singh
This network shows the impact of papers produced by Dave Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dave Singh. The network helps show where Dave Singh may publish in the future.
Co-authors
The 25 scholars most cited alongside Dave Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 590 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary Hit paper breakdown → | 2017 | 2553 |
| 2 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 Hit paper breakdown → | 2019 | 1420 |
| 3 | Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD Hit paper breakdown → | 2018 | 919 |
| 4 | Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary Hit paper breakdown → | 2023 | 767 |
| 5 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Hit paper breakdown → | 2017 | 723 |
| 6 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary Hit paper breakdown → | 2017 | 553 |
| 7 | Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease Hit paper breakdown → | 2020 | 551 |
| 8 | Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report Hit paper breakdown → | 2017 | 523 |
| 9 | Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary Hit paper breakdown → | 2023 | 490 |
| 10 | Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD Hit paper breakdown → | 2020 | 469 |
| 11 | Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial Hit paper breakdown → | 2018 | 467 |
| 12 | Eosinophilic inflammation in COPD: prevalence and clinical characteristics Hit paper breakdown → | 2014 | 404 |
| 13 | Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial Hit paper breakdown → | 2020 | 346 |
| 14 | 2015 | 342 | |
| 15 | Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial Hit paper breakdown → | 2017 | 329 |
| 16 | Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts Hit paper breakdown → | 2023 | 329 |
| 17 | Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial Hit paper breakdown → | 2016 | 329 |
| 18 | 2019 | 293 | |
| 19 | 2017 | 270 | |
| 20 | Benralizumab for the Prevention of COPD Exacerbations Hit paper breakdown → | 2019 | 267 |
About Dave Singh
Dave Singh is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Emergency Medical Services, Immunology and Immunology and Allergy, having authored 590 papers that have together received 30.1k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (340 papers), Asthma and respiratory diseases (240 papers), Respiratory Support and Mechanisms (89 papers), Respiratory and Cough-Related Research (70 papers), Inhalation and Respiratory Drug Delivery (49 papers), Pediatric health and respiratory diseases (28 papers), Neonatal Respiratory Health Research (19 papers) and Phosphodiesterase function and regulation (14 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (19.0k citations), Physiology (9.6k citations), Emergency Medical Services (1.6k citations), Issues, ethics and legal aspects (221 citations) and Immunology (1.9k citations). Dave Singh has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Jørgen Vestbo, ALBERTO PAPI, David M.G. Halpin, Fernando J. Martínez, Andrew J. Higham, Alvar Agusti Garcia-Navarro, Umme Kolsum, Simon Lea, Jadwiga Anna Wedzicha and Ruth Tal‐Singer. Their work appears in journals such as Respiratory Research, European Respiratory Journal, International Journal of COPD, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.